Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
New York, NY
SEC filing record 1 source field available
Fiscal year end
31 March
Protagenic Therapeutics, Inc.\new has filed 705 SEC EDGAR filings since 22 Oct 1996

SEC filing history

Showing 1-25 of 448 matching filings.

Per page
25
Current page
1
4

4

Filing date
24 Aug 2026
Reporting date
21 Aug 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
20 Aug 2026
Reporting date
20 Aug 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
20 Aug 2026
Reporting date
19 Aug 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-Q File 001-12555

NT 10-Q

Filing date
14 Aug 2026
Reporting date
30 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
12 Aug 2026
Reporting date
11 Aug 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
10 Aug 2026
Reporting date
06 Aug 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
06 Aug 2026
Reporting date
05 Aug 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
03 Aug 2026
Reporting date
30 Jul 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-K File 001-12555

NT 10-K

Filing date
30 Jun 2026
Reporting date
31 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-Q File 001-12555

NT 10-Q

Filing date
18 Feb 2026
Reporting date
31 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
25-NSE File 001-12555

25-NSE filing

Filing date
23 Jan 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-12555

DEF 14A

Filing date
05 Dec 2025
Reporting date
05 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-Q File 001-12555

NT 10-Q

Filing date
14 Nov 2025
Reporting date
30 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .